| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/06/2004 | WO2004038010A1 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 05/06/2004 | WO2004038004A2 Fibrin-based tissue-engineered vasculature |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004038002A2 Modulation of dendritic cell function and other cellular responses mediated by defensin compositions |
| 05/06/2004 | WO2004037982A2 High expression locus vector based on ferritin heavy chain gene locus |
| 05/06/2004 | WO2004037975A2 Composition and method for imaging cells |
| 05/06/2004 | WO2004037969A2 Advanced roller bottle system for cell and tissue culturing |
| 05/06/2004 | WO2004037847A2 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | WO2004037195A2 Treatment of diabetes |
| 05/06/2004 | WO2004037188A2 Cardiac muscle regeneration using mesenchymal stem cells |
| 05/06/2004 | WO2004027051A3 Use of a fusion polypeptide for obtaining pluripotent nonembryonic stem cells |
| 05/06/2004 | WO2004017895A3 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004015090A3 Innervated artificial tissues and uses thereof |
| 05/06/2004 | WO2004001367A3 Test system for identifying cancerous diseases |
| 05/06/2004 | WO2003103389A3 Cryopreservation of haptenized tumor cells |
| 05/06/2004 | WO2003100028A3 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 05/06/2004 | WO2003099997A3 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003072801A3 Compositions and method for regulation of calcium-dependent signalling in brain |
| 05/06/2004 | WO2003031567A9 Precursor conversion screening methods |
| 05/06/2004 | WO2003026578A9 Pine cone extracts and uses thereof |
| 05/06/2004 | WO2003024200A8 Production of transgenic birds using stage x primordial germ cells |
| 05/06/2004 | WO2003010314A3 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 05/06/2004 | WO2002091995A8 Method to induce neovascular formation and tissue regeneration |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | WO2002000838A3 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 05/06/2004 | US20040088766 Genes regulating circadian clock function and photoperiodism |
| 05/06/2004 | US20040088763 Comprises nucleotide sequences coding protein which induces flowering in plants; genetic engineering and rice yields |
| 05/06/2004 | US20040088762 Comprises DNA for identification of nucleotide sequences associated with miniaturization of plants; insect resistance |
| 05/06/2004 | US20040088758 Seed oil from helianthus with increased stearic acid and oleoic acid concentrations; food processing; cosmetics |
| 05/06/2004 | US20040088756 Identifying diseases resistance gene in plants |
| 05/06/2004 | US20040088754 Comprises nucleotide sequences comprising heterologous polypeptide gene, signal sequences and seed maturation promoter for transformation and expression of polypeptide in preferential tissue/compartments of plants; bioreactors |
| 05/06/2004 | US20040088746 Apoptosis-inducing dna sequences |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087774 Comprises tumor necrosis factor receptor associated factor-(TRAF) inhibitor for diagnosis, prevention and tratment of tumors associated wit h epstein-barr virus |
| 05/06/2004 | US20040087770 Viral peptide for use in diagnosing, preventing and treating sepsis and meningitis; microbiocides; vaccine development |
| 05/06/2004 | US20040087769 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087532 Vaccine comprising antigen presenting cells loaded with at least two tumor antigens and/or tumor antigen derived peptides |
| 05/06/2004 | US20040087526 Therapeutically useful compositions of DNA-RNA hybrid duplex constructs |
| 05/06/2004 | US20040087524 Agent for postoperative use after removal of bone tumours |
| 05/06/2004 | US20040087485 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 05/06/2004 | US20040087482 Microparticle-drug conjugates for biological targeting |
| 05/06/2004 | US20040087481 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 05/06/2004 | US20040087478 Discovering pain regulating substances; incubating with then measuring binding to cell synthesized peptide or protein |
| 05/06/2004 | US20040087026 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 05/06/2004 | US20040087025 Transfering genetic material into proliferating lymphocytes using phorbol ester, calcium ionophores and lymphocyte receptor/CD3 complexes; gene therapy |
| 05/06/2004 | US20040087023 Methods of determining deficiencies in intracellular levels of cysteine and glutathione |
| 05/06/2004 | US20040087022 Dry powder cells and cell culture reagents and methods of production thereof |
| 05/06/2004 | US20040087021 Nutrient broth comprising sodium erythorbate for propagating eukaryotic cells; bioreactors and heterologous protein expression |
| 05/06/2004 | US20040087020 Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
| 05/06/2004 | US20040087019 Method and system for myocardial infarction repair |
| 05/06/2004 | US20040087018 Using vitamin d3, cytokine, antibody and dexamethasone mixture to identify and treat inflammatory or autoimmune diseases |
| 05/06/2004 | US20040087017 Method for isolation of cells from a solution |
| 05/06/2004 | US20040087016 Using cyclin dependent kinase inhibitors to return differentiated cells to pluripotent state; tissue engineering and organ transplantation |
| 05/06/2004 | US20040087015 Polysaccharides; antidiabetic agents; Parkinson's disease |
| 05/06/2004 | US20040087014 Eukaryotic expression libraries and methods of use |
| 05/06/2004 | US20040087013 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 05/06/2004 | US20040086995 Comprises enzymatic polypeptide associated with modifying half-lives of protein present in circulatory system: proteomics |
| 05/06/2004 | US20040086993 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 05/06/2004 | US20040086981 Using vascular endothelial cells to propagate saccharides for use in drug development, medicines and microarrays |
| 05/06/2004 | US20040086979 Preparing monoclonal antibody with reduced immunogenicity; diagnostic tools; immunotherapy |
| 05/06/2004 | US20040086974 Comprises human tumor suppressor protein for treatment and prevention of cell proliferative disorders; antitumor/anticarcinogenic/antiproliferative agents |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086971 Comprises nucleotide sequences coding extracellular matrix protein for prevention and treatment of inflammatory, immune and thrombotic disorders |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086960 Transgenic cell expressing human leukocyte antigen fusion proteins for induction of cytotoxic T cell responses against viral and tumor antigens; immunotherapy |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086934 Comprises striamin polypeptide for identifying modulator for treatment and prevention of cardiovascular, tumor and muscle disorders |
| 05/06/2004 | US20040086933 Protein and gene involved in myocyte differentiation |
| 05/06/2004 | US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders |
| 05/06/2004 | US20040086919 Comprises regulatory nucleotide sequences for identifying novel therapeutic agents for treatment of breast, bone marrow, pain, arthritic, behavioral, depression and hematopoietic disorders |
| 05/06/2004 | US20040086913 Human genes and gene expression products XVI |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086902 Comprises nucleotide sequences coding fructosyltransferase for preparation of fructooligosaccharides and difructose dianhydrides for use as dietetic food or animal feed additive |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086884 Using gene-targeted double stranded RNA (dsRNA) to inhibit preferential gene expression in cells; targeted tissue gene therapy |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086859 Identification of a dual specificity phosphate: dusp-10 |
| 05/06/2004 | US20040086858 Identification of new human gaba transporter |
| 05/06/2004 | US20040086847 Cestrum yellow leaf curling virus promoters |
| 05/06/2004 | US20040086544 Polymers with bioactive agents |
| 05/06/2004 | US20040086530 Transgenic plant or plant cell that, when consumed as a foodstuff in four or less feedings, elicits an anti-HBsAg boosting immune response that increases serum anti-HBsAg antibody levels at least four-fold |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086517 Porous, implantable device containing a fibrous support and at least one antigen |
| 05/06/2004 | US20040086516 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | US20040086502 Has a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for said antigen |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | US20040086497 Cell-matrix structure for implantation stably expressing a gene encoding at least one biological modifier to stop or regress excessive tissue proliferation |
| 05/06/2004 | US20040086494 Immune privileged cells for delivery of proteins and peptides |
| 05/06/2004 | US20040086493 That can be polymerized in contact with living cells and tissues, and in a very short time period that can be polymerized in contact with living cells and tissues, and in a very short time period. |
| 05/06/2004 | EP1416280A2 Antibodies specific for native PrPsc |
| 05/06/2004 | EP1416272A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson's disease |
| 05/06/2004 | EP1416044A1 Support for cell / tissue culture and culture method |
| 05/06/2004 | EP1416043A1 Leguminous bacterium having potentiated nitrogen fixation ability |
| 05/06/2004 | EP1416042A1 Apparatus for culture, process for preparing apparatus for culture, and culturing method |